HOME SITEMAP FEEDBACK HELP RECOMMEND THIS SITE
Search         Archive
 
A d v e r t i s e m e n t
asdf
 
 
 Home > Top Story
Waiting to bloom with just Rs 200 crore
N SURESH
Monday, May 19, 2003
TDB opens the purse for biotech firms

In recent years, the Technology Development Board (TDB) in the Department of Science and Technology (DST) has emerged as the major funding organization for the biotechnology sector. TDB was set up on September 1, 1996, to channel the funds generated through a 5 percent cess levied on all technology imports into India. The board draws its powers from the Technology Development Board Act, 1995.

TDB invests in equity capital or gives soft loans to industrial units, cooperatives and other agencies, as applicable, attempting development and commercial application of indigenous technology, or adapting importing technology to wider domestic applications. The board invests up to 25 percent in equity shares of the total project cost, including margin money for working capital. However, this investment will not exceed the paid-up share capital of the promoters. In some cases, instead of equity shares, soft loans at 5 percent annual interest rate is given on the basis of collateral guarantees for the duration of the project up to a maximum of three years. The repayments have to be done in five years and it starts a year after the completion of the project.

A strong linkage with government institutions is a must. For projects involving commercialization of technologies developed by a government institution, the company applying for assistance should have an agreement with the technology developing organization. TDB will also provide assistance to projects for commercialization developed with the financial support under the Home Grown Technology/mission projects/Technology Vision 2020 implementation projects of the Technology Information, Forecasting and Assessment Council (TIFAC). Projects supported by other government projects like the PATSER (Program Aimed at Technological Self Reliance) of the Department of Scientific and Industrial Research (DSIR) or the Technopreneur Promotion Program (TePP).

Where legal title to domestically generated intellectual property is held by an inventor of such property or by an industrial concern, such individual or industrial concern is also eligible to apply. In the case of commercializing imported technology, the board provides financial assistance mainly for effecting crucial modifications for wider domestic applications through a recognized R&D institution or through an individual or industrial concern and for further development of commercializable technology, imported when that technology is at "proof of concept" or design stage.

However, funding from the TDB is not available for refinancing, basic research, establishment of new R & D centers, any forms of grants-in-aid or loan for the mere creation of technical infrastructure and more than two projects at one time to an industrial enterprise.

Enterprise Project Cost  TDB Assistance Project
Shanta Biotechnics INR 252.6 mn INR 85 mn  (33 percent of total cost) Development and commercialization of recombinant Hepatitis B Vaccine
Shanta Biotechnics
 
 INR 244 mn INR 122mn (50 percent of total cost) Development and commercialization of recombinant human Interferon alpha 2
Bharat Biotech INR 1221.1mn INR 32.5 mn Development and commercialization
of recombinant Hepatites B Vaccine
Bharat Biotech INR 235 mn INR 110 mn (46.8 percent of Development and commercialization of recombinant Sreptokinase

 

Mark Medicines INR 265.7 mn INR 70 mn (26.3 percent of total cost) Commercialization of Biobacton - a  contrate of living lactic acid bacteria total cost) possessing high probiotic and acidogenic qualities is used for preventing the development of conditional pathogenic and eteropathogenic flora in the intestine. The technology has been provided by Ministry of Atomic Energy, Russian Federation
Prathista Industries INR 104.6 mn INR 40 mn (38 percent of total cost) Manufacture of Gluconic Acid and its salts through cost-effective fermentation process developed by Regional Research Laboratory, Jammu
Shantha Marine Biotechnologies Pvt. Ltd. INR 95 mn INR 35 mn (36.8 percent of Cost) Extraction of natural Beta Carotene by setting up the production facilities for cultivation of Marine Micro Algea Dunaliella Salina in sea water with technology from ABL Biotechnologies Ltd.
Ajay Biotech (India) Ltd. INR 25mn INR 12.5mn (50 percent of total cost) Development, scale-up and manufacture of bio-pesticide based on Bacillus thruingiensi (Bt)
SPIC Ltd. INR 25 mn INR 11.3 mn Commercialization of technology for production of industrial enzymes-Alpha-amylase and Tannase
Javeri Agro Industrial & Investment Co.Ltd INR 16.3 mn INR 4 mn (24.4 percent of total cost) Manufacture of Rhizobium based bio-fertiliser and Trichoderma  (bio-control agent)

Next Page : List of biotech venture capitalists


Page(s)   1  2  3  4  5  6  7  

 



Current Issue

Special Issue
 
Read Testimonials
EDITORIAL
BIONEWS
NEWS ANALYSIS
 
 

 

 


Google Web biospectrumindia.com
Other CyberMedia websites
Dataquest |  Voice&Data |  PCQuest |  Living Digital |  DQ Channels |  The DQweek
CIOL |  IDC India |  CIOL Shop |  CyberMedia Dice |  CyberMedia Events |  CyberMedia Digital
Cyber Astro |  CyberMedia India |  Global Services |  BioSpectrum Asia

   About BioSpectrum | Feedback | Contact Us

 
Copyright © CyberMedia All rights reserved. 
Reproduction in whole or in part in any form or medium without express written permission is prohibited. 
Usage of this web site is subject to terms and conditions.

Broken links? Problem with site? Send email to webmaster@cybermedia.co.in